Docetaxel in Locally Advanced Gastric Adenocarcinoma
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Study objectives:
To determine Ro resection rate of Docetaxel, cisplatin and fluorouracil combination for the
treatment of neoadjuvant gastric carcinoma.